Literature DB >> 7117327

Mucosal blood flow and modified vascular responses to norepinephrine in the stomach of rats with liver cirrhosis.

S Kitano, N Koyanagi, K Sugimachi, M Kobayashi, K Inokuchi.   

Abstract

To observe changes in hemodynamics and vascular responses to norepinephrine in cases of liver cirrhosis, male WKA rats were given CCl4 subcutaneously. The portal venous pressure of these so-induced cirrhotic rats was significantly higher than that of the controls. There was an increase of mucosal blood flow and a lowering of peripheral vascular resistance of the stomach. After norepinephrine infusion, the gastric mucosal blood flow increased significantly in cirrhotic rats, whereas there was no significant change in controls. The aorta and the portal vein showed no difference in the vascular response to either norepinephrine or [K+].0. These results suggest that in cirrhotic rats there is an increase in blood flow and a lowering of peripheral vascular resistance in the gastric mucosa and that these hemodynamic changes may be derived from alteration in the vascular response to norepinephrine in gastric microcirculation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7117327     DOI: 10.1159/000128292

Source DB:  PubMed          Journal:  Eur Surg Res        ISSN: 0014-312X            Impact factor:   1.745


  3 in total

1.  New insights into impairment of mucosal defense in portal hypertensive gastric mucosa.

Authors:  M Tomikawa; Y Akiba; J D Kaunitz; H Kawanaka; K Sugimachi; I J Sarfeh; A S Tarnawski
Journal:  J Gastrointest Surg       Date:  2000 Sep-Oct       Impact factor: 3.452

2.  Discrimination between Portal Hypertensive Gastropathy and Helicobacter pylori-related Gastritis.

Authors:  Yoshihiro Furuichi; Yohei Koyama; Masakazu Abe; Yuu Yoshimasu; Hirohito Takeuchi; Takao Itoi
Journal:  Intern Med       Date:  2022-03-01       Impact factor: 1.271

3.  Portal Hypertensive Gastropathy in Liver Cirrhosis: Prevalence, Natural History, and Risk Factors.

Authors:  Ken Nishino; Miwa Kawanaka; Noriaki Manabe; Mitsuhiko Suehiro; Hirofumi Kawamoto; Ken Haruma
Journal:  Intern Med       Date:  2022-03-01       Impact factor: 1.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.